Dutch Cancer Society

• Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

  Collaborator, Phase 3, Recruiting, 316 people, 24 Feb 2022

• NCT05076942

  Collaborator, Phase 2, Recruiting, 157 people, 13 Oct 2021

• NCT04927780

  Collaborator, Phase 3, Active, not recruiting, 378 people, 16 Jun 2021

• NCT04729543

  Collaborator, Phase 1/2, Recruiting, 20 people, 28 Jan 2021

• NCT04099901

  Collaborator, Phase 2, Completed, 88 people, 23 Sept 2019

• NCT03749850

  Collaborator, Phase 1, Status unknown, 12 people, 21 Nov 2018

• NCT02170090

  Collaborator, Phase 3, Active, not recruiting, 789 people, 23 Jun 2014

• NCT01462214

  Collaborator, Phase 1/2, Completed, 96 people, 31 Oct 2011

• NCT01099436

  Collaborator, Phase 3, Completed, 250 people, 7 Apr 2010

• NCT00844506

  Collaborator, Phase 2, Completed, 19 people, 16 Feb 2009

• NCT00808743

  Collaborator, Phase 2/3, Completed, 37 people, 16 Dec 2008

• NCT00319007

  Collaborator, Phase 2, Status unknown, 30 people, 27 Apr 2006

• NCT00208546

  Collaborator, Phase 3, Completed, 750 people, 21 Sept 2005

Sources: clinicaltrials.gov

• Toward Objective Anal Cancer Screening: From Swab-Based Genome-Wide Methylation Marker Discovery to Novel Test Development

  KWF17009, 27 Aug 2026

• Linking dementia prodromes and cancer through motor function impairment: the Rotterdam-Study

  NKI-202214514, 25 Jul 2026

Sources: pubmed.ncbi.nlm.nih.gov, api.crossref.org